Clinical trial
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women and Sheep
NCT06686537 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Convergent Mechanisms Underlying Reprometabolic Syndrome in Women and Sheep
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 25, 2025
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.